NOXOF
Price:
$0.045
Market Cap:
$27.18M
Noxopharm Limited, a drug development company, focuses on developing treatment options for a range of solid tumor cancers and septic shock in Australia and internationally. It primarily develops Veyonda, which is an adjuvant therapy in chemotherapy and radiotherapy for the treatment of late-stage cancers. The company also develops DARRT program that is in Phase 1b/2a for the treatment of metastatic castration-resistant prostate cancer and other solid tumors; LuPIN with combined therapy of Veyonda and 177Lu-PSMA-617 for the treatment of late-stage prostate cancer; IONIC program with Veyonda, which is combined with the Bristol Myers Squibb checkpoint inhibitor Opdivo for the treatment of vario...[Read more]
Industry
Biotechnology
IPO Date
2020-01-29
Stock Exchange
OTC
Ticker
NOXOF
According to Noxopharm Limited’s latest financial reports and current stock price. The company's current ROE is -194.85%. This represents a change of 26.73% compared to the average of -153.75% of the last 4 quarters.
The mean historical ROE of Noxopharm Limited over the last ten years is 979.09%. The current -194.85% ROE has changed -119.90% with respect to the historical average. Over the past ten years (40 quarters), NOXOF's ROE was at its highest in in the June 2019 quarter at 6.72%. The ROE was at its lowest in in the June 2025 quarter at -528.78%.
Average
979.09%
Median
-71.26%
Minimum
-707.89%
Maximum
11.15%
Discovering the peaks and valleys of Noxopharm Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 987.15%
Maximum Annual ROE = 11.15%
Minimum Annual Increase = -6287.39%
Minimum Annual ROE = -707.89%
| Year | ROE | Change |
|---|---|---|
| 2025 | -707.89% | 987.15% |
| 2024 | -65.11% | -60.76% |
| 2023 | -165.94% | 114.40% |
| 2022 | -77.40% | 237.66% |
| 2021 | -22.92% | 984.44% |
| 2020 | -2.11% | -100.02% |
| 2019 | 11.15% | -6287.39% |
| 2018 | -180.17% | 45.96% |
| 2017 | -123.44% | 941.51% |
The current ROE of Noxopharm Limited (NOXOF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages
3-year avg
-312.98%
5-year avg
-207.85%
10-year avg
979.09%
Noxopharm Limited’s ROE is less than Rapid Dose Therapeutics Corp. (105.94%), less than Poxel S.A. (104.21%), greater than Sorrento Therapeutics, Inc. (-1904.94%), greater than Eiger BioPharmaceuticals, Inc. (-367.00%), greater than Ceapro Inc. (-15.66%), less than American Hemp Ventures, Inc. (0%), greater than RAMM Pharma Corp. (-85.22%), less than Nurosene Health Inc. (0%), greater than Simply Better Brands Corp. (-16.72%), less than Lifeist Wellness Inc. (20.65%),
| Company | ROE | Market cap |
|---|---|---|
| 105.94% | $19.93M | |
| 104.21% | $13.42M | |
| -1904.94% | $16.54M | |
| -367.00% | $12.59M | |
| -15.66% | $13.31M | |
| 0% | $16.47M | |
| -85.22% | $15.16M | |
| 0% | $14.25M | |
| -16.72% | $14.81M | |
| 20.65% | $15.76M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Noxopharm Limited using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Noxopharm Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Noxopharm Limited's ROE?
How is the ROE calculated for Noxopharm Limited (NOXOF)?
What is the highest ROE for Noxopharm Limited (NOXOF)?
What is the 3-year average ROE for Noxopharm Limited (NOXOF)?
What is the 5-year average ROE for Noxopharm Limited (NOXOF)?
How does the current ROE for Noxopharm Limited (NOXOF) compare to its historical average?